PARIS--(BUSINESS WIRE)--Groupe Gorgé announced four sales of new 3D printers in first-half 2014 to three customers. These machines will be delivered during the financial year, in addition to the three machines previously announced for delivery in 2014.
These new machines were sold in France and Germany, mainly for biomedical production applications but also for research and rapid prototyping. Two sales concern Prodways’ most recent M350 model, and offers the highest productivity levels of the range.
The significance of this sales success is added to by the fact that the sales were set in motion prior to the acquisition of Deltamed, when the Group did not have a proprietary resin solution for 3D printers. The machines will operate using the resins sold by the Group.
Groupe Gorgé continues its rapid growth in the 3D printing segment, for which it has global ambitions. Prodways, Deltamed and Prodways Entrepreneurs form the main pillars of this business and staff have been increased from one to 66 in the space of a year.
About Groupe Gorgé:
Established in 1990, Groupe Gorgé is an industrial group operating in different areas of expertise: Smart Safety Systems, Protection in Nuclear Environments, Industrial Projects & Services and 3D Printing
In 2013, the Group reported revenue of €214.5 million. It is backed by 1,300 employees and operations in over ten countries. Groupe Gorgé is listed on NYSE Euronext Paris (ISIN: FR0000062671; Ticker code: GOE) and on the US OTC market (ISIN: US3994511034; OTC Pink: GGRGY / GGRGF) in the form of ADR.
More information available on www.groupe-gorge.com